Intel Just Shocked Everyone, but Is the Stock Still a Buy?

Intel reported Q1 revenue of $13.6B, up 7% year over year, with adjusted EPS of $0.29 versus $0.01 expected. AI data center revenue rose 22% to $5.1B, gross margin improved 250bps to 39.4%, and Q2 guidance of $13.8B-$14.8B revenue and $0.20 adjusted EPS topped consensus. Despite the beat, the stock has roughly doubled in less than a month and now screens at a forward P/E of 161, making the setup look valuation-stretched.

Analysis

The market is starting to price Intel as if the server-CPU rebound is a durable secular rerating, but the more actionable read is that this is a cyclical demand catch-up with a high-beta squeeze overlay. If hyperscalers are rebalancing toward CPU-heavy inference architecture, that helps every x86 supplier, but Intel’s true operating leverage is still constrained by foundry drag and capital intensity, which means earnings power can lag the headline revenue inflection by several quarters.

The second-order winner is AMD, not Intel. Intel’s recovery narrative tends to force buyers back into the whole data-center CPU complex, but AMD has the cleaner mix, better credibility on share gains, and less embedded execution risk in manufacturing. That makes Intel’s surge likely to spill over into AMD on relative valuation grounds even if AMD doesn’t print the same near-term upside surprise.

The main risk is that the current move is front-loading 12-18 months of good news into a stock that still carries turnaround risk. If client PC demand weakens as guided, or if server demand normalizes after the current AI-inference buildout, the multiple can compress quickly because the stock is no longer being valued as a distressed asset. Any disappointment on foundry losses or gross margin cadence would likely hit hard given how crowded the bullish rerating has become.

Consensus is missing that the real trade is not "Intel fixed," but "AI infrastructure is broadening from accelerators into supporting compute." That broadening favors a basket approach and makes the current Intel valuation look too rich for a company still proving execution. The move is likely overdone in the short term, even if the underlying CPU demand trend remains intact into next year.

Key Decisions for Investors

• Short INTC on strength or via call spread overlays into the next 2-6 weeks; the setup is asymmetric because the stock has already discounted multiple quarters of good execution while structural risks remain unresolved.
• Long AMD vs. short INTC as a relative-value pair for the next 3-12 months; AMD has the cleaner participation in the same server-CPU trend with less balance-sheet and foundry noise.
• If expressing the thematic view, prefer a basket long AMD/NVDA over INTC; the upside from AI infrastructure broadening is higher quality in names with stronger moats and less turnaround execution risk.
• Use INTC put spreads 3-6 months out if the stock continues to gap on analyst upgrades; you want to monetize valuation compression rather than fight the near-term momentum head-on.
• Trim or avoid initiating fresh INTC longs above the current rerating zone unless you have conviction that server CPU demand stays strong through 2027; the risk/reward is unfavorable versus peers with better operating leverage.